Literature DB >> 30874612

bTMB is a promising predictive biomarker.

David Killock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30874612     DOI： 10.1038/s41571-019-0202-8

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  6 in total

Review 1.  Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.

Authors:  Mengke Niu; Ming Yi; Ning Li; Suxia Luo; Kongming Wu
Journal:  Exp Hematol Oncol       Date:  2021-03-02

2.  Highly Multiplexed Digital Spatial Profiling of the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Patients.

Authors:  Arutha Kulasinghe; Touraj Taheri; Ken O'Byrne; Brett G M Hughes; Liz Kenny; Chamindie Punyadeera
Journal:  Front Oncol       Date:  2021-01-19       Impact factor: 6.244

3.  On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.

Authors:  Tao Jiang; Jianhua Chen; Xingxiang Xu; Ying Cheng; Gongyan Chen; Yueyin Pan; Yong Fang; Qiming Wang; Yunchao Huang; Wenxiu Yao; Rui Wang; Xingya Li; Wei Zhang; Yanjun Zhang; Sheng Hu; Renhua Guo; Jianhua Shi; Zhiwu Wang; Peiguo Cao; Donglin Wang; Jian Fang; Hui Luo; Yi Geng; Chunyan Xing; Dongqing Lv; Yiping Zhang; Junyan Yu; Shundong Cang; Yaxi Zhang; Jiao Zhang; Zeyu Yang; Wei Shi; Jianjun Zou; Caicun Zhou; Shengxiang Ren
Journal:  Mol Cancer       Date:  2022-01-03       Impact factor: 27.401

Review 4.  The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer.

Authors:  Jiayan Wei; Jia Feng; Yiming Weng; Zexi Xu; Yao Jin; Peiwei Wang; Xue Cui; Peng Ruan; Ruijun Luo; Na Li; Min Peng
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

5.  ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis.

Authors:  Yanna Zhang; Ting Du; Xiancheng Chen
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

6.  Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors.

Authors:  Zi-Ming Wang; Qi-Rong Xu; David Kaul; Mahmoud Ismail; Harun Badakhshi
Journal:  Thorac Cancer       Date:  2021-05-25       Impact factor: 3.500
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.